Association of Hypertension with Severity and Mortality in Hospitalized Patients with COVID-19 in Wuhan, China: A

You-Ping Deng1, Wen Xie2, Tao Liu3

  • 1Department of Pediatrics, Zhongnan Hospital of Wuhan University, Wuhan - China.

Insights

Hypertension is linked to increased severity and mortality in hospitalized COVID-19 patients. Early, aggressive treatment for these patients, particularly for cardiac and kidney issues, is recommended.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, has led to a global pandemic.
  • Understanding comorbidities associated with severe COVID-19 outcomes is crucial for patient management.
  • Hypertension is a prevalent comorbidity with potential implications for COVID-19 prognosis.

Purpose of the Study:

  • To investigate the association between hypertension and the severity and mortality of COVID-19 in hospitalized patients.
  • To identify clinical characteristics and outcomes of COVID-19 patients with and without hypertension.

Main Methods:

  • Retrospective, single-center case study involving 337 hospitalized COVID-19 patients.
  • Data collected from January 20 to February 25, 2020, at the Seventh Hospital of Wuhan City.
  • Statistical analysis performed with a significance level of 0.05.

Main Results:

  • Of 337 patients, 112 (33.2%) had hypertension. Hypertensive patients were older and predominantly male.
  • Hypertension was significantly associated with increased severity (severe/critical cases) and higher mortality rates (17.9% vs. 8.9%).
  • Hypertensive patients exhibited more abnormal laboratory findings, including lymphopenia, inflammation, and impaired cardiac, liver, kidney, and lung function.

Conclusions:

  • Hypertension is a significant risk factor for severe COVID-19 outcomes and mortality.
  • COVID-19 patients with hypertension require vigilant monitoring for cardiac and kidney complications.
  • Aggressive treatment strategies should be considered for hypertensive COVID-19 patients to mitigate adverse outcomes.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
116
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
203
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
191
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.4K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
92
Measurement of Blood Pressure01:17

Measurement of Blood Pressure

Assessing blood pressure is a standard procedure executed in virtually all medical environments. The method utilized today was established over a hundred years ago by an innovative Russian doctor, Dr. Nikolai Korotkoff. The soft ticking noise, known as Korotkoff sounds, heard while taking blood pressure readings results from turbulent blood flow within the vessels. The apparatus required for this procedure includes a sphygmomanometer, a blood pressure cuff attached to a gauge, and a...
1.9K